These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

188 related items for PubMed ID: 9641169

  • 21. Increased urinary excretion of thromboxane B2 and 2,3-dinor-TxB2 in cyclosporin A nephrotoxicity.
    Benigni A, Chiabrando C, Piccinelli A, Perico N, Gavinelli M, Furci L, Patino O, Abbate M, Bertani T, Remuzzi G.
    Kidney Int; 1988 Aug; 34(2):164-74. PubMed ID: 3184595
    [Abstract] [Full Text] [Related]

  • 22. Production of less chronic nephrotoxicity by cyclosporine G than cyclosporine A in a low-salt rat model.
    Burdmann EA, Rosen S, Lindsley J, Elzinga L, Andoh T, Bennett WM.
    Transplantation; 1993 May; 55(5):963-6. PubMed ID: 8497907
    [Abstract] [Full Text] [Related]

  • 23. Image analyser as a tool for the study of in vitro glomerular vasoreactivity.
    Lakhdar B, Potier M, L'Azou B, Cambar J.
    Cell Biol Toxicol; 1994 Dec; 10(5-6):291-5. PubMed ID: 7697487
    [Abstract] [Full Text] [Related]

  • 24. Implication of CYP 3A in the toxicity of cyclosporin G (CsG), cyclosporin A (CsA) and FK506 on rat hepatocytes in primary culture.
    Ellouk-Achard S, Martin C, Pham-Huy C, Duc HT, Thevenin M, Dutertre-Catella H, Warnet JM, Claude JR.
    Arch Toxicol; 1997 Dec; 71(7):437-42. PubMed ID: 9209689
    [Abstract] [Full Text] [Related]

  • 25. Effects of leukotrienes on isolated rat glomeruli and cultured mesangial cells.
    Barnett R, Goldwasser P, Scharschmidt LA, Schlondorff D.
    Am J Physiol; 1986 May; 250(5 Pt 2):F838-44. PubMed ID: 3706536
    [Abstract] [Full Text] [Related]

  • 26. [Demonstration of direct vasoconstrictive effect of cyclosporin on glomeruli isolated from human kidney].
    Gonzalez R, Lakhdar B, Redon P, Potaux L, Cambar J, Aparicio M.
    C R Acad Sci III; 1990 May; 311(3):109-14. PubMed ID: 2119861
    [Abstract] [Full Text] [Related]

  • 27. Dopamine attenuates the contractile response to angiotensin II in isolated rat glomeruli and cultured mesangial cells.
    Barnett R, Singhal PC, Scharschmidt LA, Schlondorff D.
    Circ Res; 1986 Nov; 59(5):529-33. PubMed ID: 3467880
    [Abstract] [Full Text] [Related]

  • 28. [Protective effect of verapamil and dopamine against cyclosporine-induced vasoconstriction in isolated glomeruli in rats].
    L'Azou B, Lagroye I, Plande J, Lakhdar B, Cambar J.
    Presse Med; 1992 Dec 02; 21(41):2021-3. PubMed ID: 1294973
    [Abstract] [Full Text] [Related]

  • 29. A comparative toxicological study of cyclosporine and Nva2-cyclosporine in Sprague-Dawley rats.
    Duncan JI, Thomson AW, Simpson JG, Davidson RJ, Whiting PH.
    Transplantation; 1986 Oct 02; 42(4):395-9. PubMed ID: 3765053
    [Abstract] [Full Text] [Related]

  • 30. Increased glomerular cell heparan sulfates in vitro by ciclosporin A: a Possible explanation of Its beneficial effect in idiopathic nephrotic syndrome.
    Birmelé B, De Agostini A, Girardin EP.
    Nephron; 2001 Jun 02; 88(2):156-62. PubMed ID: 11399919
    [Abstract] [Full Text] [Related]

  • 31. Effects of cyclosporin and FK-506 on glomerular mesangial cells. Evidence for direct inhibition of thromboxane synthase by low cyclosporin concentrations.
    Radeke HH, Kuster S, Kaever V, Resch K.
    Eur J Clin Pharmacol; 1993 Jun 02; 44 Suppl 1():S11-6. PubMed ID: 7683610
    [Abstract] [Full Text] [Related]

  • 32. Cyclosporin A inhibits prostaglandin E2 formation by rat mesangial cells in culture.
    Stahl RA, Adler S, Baker PJ, Johnson RJ, Chen YP, Pritzl P, Couser WG.
    Kidney Int; 1989 May 02; 35(5):1161-7. PubMed ID: 2504985
    [Abstract] [Full Text] [Related]

  • 33. Sites of biotransformation for the cyclosporin derivative SDZ IMM 125 using human liver and kidney slices and intestine. Comparison with rat liver slices and cyclosporin A metabolism.
    Vickers AE, Fisher RL, Brendel K, Guertler J, Dannecker R, Keller B, Fischer V.
    Drug Metab Dispos; 1995 Mar 02; 23(3):327-33. PubMed ID: 7628297
    [Abstract] [Full Text] [Related]

  • 34. Intrinsic properties of the nonpeptide angiotensin II antagonist losartan in glomeruli and mesangial cells at high concentrations.
    Chansel D, Badre L, Czekalski S, Vandermeersch S, Cambar J, Ardaillou R.
    J Pharmacol Exp Ther; 1993 Jun 02; 265(3):1534-43. PubMed ID: 8510026
    [Abstract] [Full Text] [Related]

  • 35. Role of endothelin in cyclosporine-induced glomerular dysfunction.
    Kon V, Sugiura M, Inagami T, Harvie BR, Ichikawa I, Hoover RL.
    Kidney Int; 1990 Jun 02; 37(6):1487-91. PubMed ID: 2194067
    [Abstract] [Full Text] [Related]

  • 36. Direct effects of platelet-activating factor on glomerular capillary permeability.
    Sharma R, Sharma M, Li JZ, McCarthy ET, Savin VJ.
    Kidney Blood Press Res; 1997 Jun 02; 20(1):25-30. PubMed ID: 9192907
    [Abstract] [Full Text] [Related]

  • 37. Effect of cyclosporin and the prostacyclin analogue iloprost on human glomerular vasoreactivity.
    Le Guen E, Morel D, L'Azou B, Cambar J, Potaux L.
    Nephrol Dial Transplant; 1994 Jun 02; 9(4):413-5. PubMed ID: 7521943
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Comparison of the effects of cyclosporin G (OG37-325), cyclosporin A, and their metabolites on the release of endothelin and prostacyclin from primary renal and aortic endothelial cell lines.
    Langman LJ, Yatscoff RW.
    Ther Drug Monit; 1994 Oct 02; 16(5):450-7. PubMed ID: 7846742
    [Abstract] [Full Text] [Related]

  • 40. Cyclosporine A-induced increase in glomerular cyclic GMP in rats and the involvement of the endothelinB receptor.
    Tack I, Marin-Castano E, Bascands JL, Pecher C, Ader JL, Girolami JP.
    Br J Pharmacol; 1997 Jun 02; 121(3):433-40. PubMed ID: 9179384
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.